Montelukast Sodium Tablet
Product Images NDC 63187-430

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 63187-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart (Montelukastir Figure 01)

A line graph depicting change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis shows weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm, illustrating growth trends over time for each group.*

FDA Label Image

Str (Montelukastir Figure 02)

Chemical structure diagram of Montelukast Sodium showing its molecular arrangement, including a chlorinated bicyclic ring, a sulfur-containing cyclopropyl group, and a sodium carboxylate moiety.*

FDA Label Image

Chart2 (Montelukastir Figure 03)

A line graph showing the mean percent change from baseline over weeks in treatment for Montelukast Sodium compared to placebo. The x-axis represents weeks in treatment (0 to 15), including a washout period from week 12 to 15. The y-axis shows mean percent change from baseline (0 to 15%). Montelukast Sodium demonstrates a higher percent change than placebo over the treatment period, with a decline during the washout phase.*

FDA Label Image

Table (Montelukastir Figure 04)

A text panel listing potential behavioral and psychological side effects including agitation, aggressive behavior, vivid dreams, depression, confusion, anxiety, hallucinations, irritability, restlessness, sleepwalking, suicidal thoughts and actions, tremor, and trouble sleeping.*

FDA Label Image

Logo (Montelukastir Figure 05)

Montelukast Sodium 10 mg oral tablets packaging label by Proficient Rx LP. The rectangular carton displays the product name prominently, strength (10 mg), dosage form (tablets), and manufacturer information. The label includes the NDC code 63187-430 and essential identification details clearly visible on a white and green background.*

FDA Label Image

63187-430-30 (Montelukastir Figure 06)

Montelukast Sodium 10 mg tablet label by Proficient Rx LP showing prescription medication details. The label indicates 30 tablets per container with each tablet containing 10.4 mg montelukast sodium equivalent to 10 mg montelukast. Tablets are light brown, round, biconvex film-coated with debossing. Manufactured by Torrent Pharmaceuticals Ltd., India, with storage instructions and a QR code visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.